Trial Profile
Phase 1 study of fixed dose combination Budesonide/azelastine in patients with seasonal allergic rhinitis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Azelastine/budesonide (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions
- 10 Dec 2015 New trial record